Cite
MLA Citation
Pierpaolo Pellicori et al.. “Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial.” European journal of heart failure, vol. 22, 2020, pp. 1711–1723. http://access.bl.uk/ark:/81055/vdc_100113737599.0x00003e